137 related articles for article (PubMed ID: 25538487)
1. Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer.
Trehan R; Seam RK; Gupta MK; Sood A; Dimri K; Mahajan R
World J Nucl Med; 2014 Sep; 13(3):163-9. PubMed ID: 25538487
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
[TBL] [Abstract][Full Text] [Related]
3. Role of
Moulika JS; Kalawat T; Manthri RG; Hulikal N; Kadiyala S; Bhargavi D; Prayaga AK
Indian J Nucl Med; 2023; 38(4):354-361. PubMed ID: 38390549
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
[TBL] [Abstract][Full Text] [Related]
5. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
[TBL] [Abstract][Full Text] [Related]
6. Role of Tc99m-Sestamibi scintimammography in assessing response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Mittal BR; Singh RK; Kumari S; Manohar K; Bhattacharya A; Singh G
Indian J Nucl Med; 2012 Oct; 27(4):221-5. PubMed ID: 24019650
[TBL] [Abstract][Full Text] [Related]
7. Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI.
Listewnik MH; Birkenfeld B; Foszczyńska-Kłoda M; Listewnik MJ; Piwowarska-Bilska H; Zorga P
Ann Acad Med Stetin; 2011; 57(1):73-8. PubMed ID: 22593995
[TBL] [Abstract][Full Text] [Related]
8. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Drucker MJ; Livingston RB
Cancer; 1999 Jun; 85(11):2410-23. PubMed ID: 10357412
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
[TBL] [Abstract][Full Text] [Related]
10. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
[TBL] [Abstract][Full Text] [Related]
11. Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
Evangelista L; Cervino AR; Michieletto S; Saibene T; Orvieto E; Bozza F; Ghiotto C
Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):205-215. PubMed ID: 25501326
[TBL] [Abstract][Full Text] [Related]
12. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Carcinoma Using Image-Guided Clip Placement.
Pandurangappa V; Paruthy SB; Jamwal R; Singh A; Tanwar S; Kumar D; Pal S; Mohan SK; Das A; Trs PR
Cureus; 2023 Oct; 15(10):e47763. PubMed ID: 38021852
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
[TBL] [Abstract][Full Text] [Related]
15. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
Guo C; Zhang C; Liu J; Tong L; Huang G
Nucl Med Commun; 2016 Jul; 37(7):675-88. PubMed ID: 26974314
[TBL] [Abstract][Full Text] [Related]
16. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
Marshall C; Eremin J; El-Sheemy M; Eremin O; Griffiths PA
Nucl Med Commun; 2005 Jan; 26(1):9-15. PubMed ID: 15604942
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
[TBL] [Abstract][Full Text] [Related]
19. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA
Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688
[TBL] [Abstract][Full Text] [Related]
20. Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.
Cayre A; Cachin F; Maublant J; Mestas D; Feillel V; Ferrière JP; Kwiaktowski F; Chevillard S; Finat-Duclos F; Verrelle P; Penault-Llorca F
Int J Oncol; 2002 May; 20(5):1049-55. PubMed ID: 11956603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
